1 / 18

Bacterial Tumor Therapy against Melanoma

Bacterial Tumor Therapy against Melanoma. Steps in melanoma progression. From: „Cellular and molecular biology of human melanoma.“, Satyamoorthy et al. Cancer Biol Ther. 2002 Jan-Feb;1(1):14-7. Ras/Raf-Singnalling. Rapp et al. From: Rapp et al. (2003) Adv Enzyme Regul. 43:183. RAF-family.

cachet
Télécharger la présentation

Bacterial Tumor Therapy against Melanoma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Bacterial Tumor Therapy against Melanoma

  2. Steps in melanoma progression From: „Cellular and molecular biology of human melanoma.“, Satyamoorthy et al. Cancer Biol Ther. 2002 Jan-Feb;1(1):14-7

  3. Ras/Raf-Singnalling Rapp et al. From: Rapp et al. (2003) Adv Enzyme Regul. 43:183

  4. RAF-family • 3 members: A-, B-, C-Raf • Constitutive low signals lead to cell proliferation and very high signals to cell cycle arrest • High levels induce p21 expression • Raf oncogene cooperates with Myc • Inactivates pro-apoptotic Bcl2 family proteins • Interacts directly with proteins like pyruvate kinase

  5. Projects • Transgenic BRafV600E mouse to determine further steps in melanoma progression, which might be useful to develop a new therapy • Bacterial tumor therapy to use bacteria to deliver a system to the tumor, that converts a prodrug into a drug

  6. Transgenic BRafV600E-mouse The expression of the BRafV600E should be tissue-specific or inducible, because the strong expression of an oncogene would probably interfere with the normal embryonal development

  7. Cre/loxP system From: „ Inducible Gene Targeting in Mice Using the Cre/lox System.“ Sauer B, A Companion to Methods in Enzymology 14, 381-392 (1998)

  8. Cloning strategy for pCMV5-NeoLoxP-BrafV600E-Myc In vitro annealing PCR XbaI overhang XbaI XbaI pCMV5 Killed XbaI site XbaI site Ligation pCMV5 pCMV5 Myc-tag Ligation CMV promotor Floxed neo B-Raf*

  9. „Tet-On“-System From: Zhou, Z. et al. (2002), Cell and Developmental Biology, 13 (121-128)

  10. pBI5-BRafV600E-Myc Ptet-bi1: bidirectional Promotor BRafV600E-Myc Luciferase

  11. Bacterial tumor therapy • Attenuated intracellular bacteria like Salmonella typhimurium or Listeria monocytogenes locate tumors • Recombinant bacteria that locate tumors, can be used to deliver a system to the tumor, that converts a prodrug into a drug

  12. Bacterial tumor therapy in melanoma Injection of recombinant Listeria monocytogenes Subcutaneous injection of B78-D14 cells Injection of the prodrug • Homogenization of the tumor • CFU • drug/prodrug concentration

  13. Bacterial tumor therapyInfection of B16-cell line with Listeria monocytogenes aroA/B • Listeria monocytogenesaroA/B strain can invade B16 cell line, although it is highly attenuated • Infection efficiency is not very high Mutagenesis might help to get a clone that gives a higher infection efficiency?

  14. Mutagenesis • Mutagenesis of Listeria with EMS • determination of the mutation rate by plating the bacteria on rifampicin plates • selection of the bacteria, that still are able to invade the cells by infection of the B16 cell-line Mutagenesis 3 x Infection

  15. Infection with mutated Listeria monocytogenes

  16. B78-D14 4T1 3T6 J774

  17. In-vivo infection with L.monocytogenes  trpS aroA/B

  18. Conclusion BRafV600E transgenic mouse might give us the possibillity to determine further steps in melanoma progression, that might be useful for developing a new therapy Mutagenesis might give us a possibility to generate a Listeria strain that is better adapted to the melanoma cells than the original strain

More Related